| 91.79 BATS BZX Real-Time Price As of 10:41am ET |  +0.23 / +0.25%Today’s Change | 73.51 Today|||52-Week Range 95.00 | +19.42% Year-to-Date |
| Here's Why Arrowhead Pharmaceuticals Is Tumbling Today Dec 04 / MotleyFool.com - Paid Partner Content | Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for Amgen Dec 02 / MotleyFool.com - Paid Partner Content |
| Here's Why The Medicines Company Jumped 60% in November Dec 03 / MotleyFool.com - Paid Partner Content | 5 New Drug Approvals the FDA Gave Top Priority Nov 29 / MotleyFool.com - Paid Partner Content |
| Previous close | 91.56 |
| Today’s open | 91.97 |
| Day’s range | 91.68 - 91.97 |
| Volume | 349,106 |
| Average volume (3 months) | 1,755,181 |
| Market cap | $208.8B |
| Earnings growth (last year) | +65.34% |
| Earnings growth (this year) | +13.58% |
| Earnings growth (next 5 years) | +9.73% |
| Revenue growth (last year) | +5.41% |
| P/E ratio | 30.3 |
| Price/Sales | 3.87 |
| Price/Book | 2.71 |
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.26 | -0.68% |
| MRKMerck | -0.36 | -0.41% |
| BMYBristol-Myers Squibb | +0.52 | +0.88% |
| ABBVAbbVie | -0.56 | -0.64% |
| Next reporting date | January 29, 2020 |
| EPS forecast (this quarter) | $1.30 |
| Annual revenue (last year) | $52.0B |
| Annual profit (last year) | $12.6B |
| Net profit margin | 24.30% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
